Skip Navigation
Skip to contents

SICEM2021

Today : 2025.06.03

D--95

Satellite Symposium

Satellite Symposium 1: Empagliflozin: Beyond the Glucose Lowering Effect Day 1, October 27(Thu), 2022 / 14:30-16:00 / Room 1

Chairperson : Ho-Sang SHON (Daegu Catholic University, Korea), Dong-Hyeok CHO (Chonnam National University, Korea)

14:30-14:50 In-depth Look at the Intersection of the Cardio-Renal Metabolic System Merlin THOMAS (Monash University, Australia)
14:50-15:10 The Expected Future Role of SGLT-2i in CKD from Nephrology Perspective Christoph WANNER (Division of Nephrology, University of Wuerzburg, Germany)
15:10-15:30 Heart Failure Management - From HFrEF to HFpEF Kyung-Hee Kim (Division of Cardiology, Incheon Sejong General Hospital, Korea)
Panel Discussion
15:30-16:00
Eu Jeong KU (Chungbuk National University, Korea)
Soo Kyoung KIM (Gyeongsang National University, Korea)
Satellite Symposium 2: Highlight the Novel Journey with New GLP1-Ras Day 1, October 27(Thu), 2022 / 14:30-16:00 / Room 2

Chairperson : Tae Keun OH (Chungbuk National University, Korea), Hyo-Jeong KIM (Eulji University, Korea)

14:30-14:50 Innovation Story of Semaglutide: Basic Research into Clinical Benefit Thomas Bo JENSEN (Novo Nordisk, Denmark)
14:50-15:10 Advanced Journey: Holistic Management with Injectable Semaglutide Nan-Hee KIM (Korea University, Korea)
15:10-15:30 New Journey: Patient-centered Care with Oral Semaglutide Adie VILJOEN (East and North Hertfordshire NHS Trust, UK)
Panel Discussion
15:30-16:00
Mi Kyung KIM (Keimyung University, Korea)
Ju Hee LEE (Chungnam National University, Korea)
Satellite Symposium 3: The Newly Updated Care for Endocrine Diseases Day 1, October 27(Thu), 2022 / 14:30-16:00 / Room 3

Chairperson : Kyoil SUH (Soonchunhyang University, Korea), Suk Kyeong KIM (Konkuk University, Korea)

14:30-14:50 Expanded Usage of Zoledronic Acid Dughyun CHOI (Soonchunhyang University, Korea)
14:50-15:10 The Cardiorenal Benefits of Dapagliflozin Miguel CAMAFORT-BABKOWSKI (University of Barcelona, Spain)
15:10-15:30 Insights to Practical Use of Ambulatory Glucose Profile in Clinical Practice Iain CRANSTON (Portsmouth Hospitals NHS Trust, UK)
Panel Discussion
15:30-16:00
Soyeon YOO (Jeju National University, Korea)
Jin Ook CHUNG (Chonnam National University, Korea)
Satellite Symposium 4: Additional Potential for DPP-4i Day 1, October 27(Thu), 2022 / 16:10-17:40 / Room 1

Chairperson : Young Il KIM (University of Ulsan, Korea), Kang Seo PARK (Eulji University, Korea)

16:10-16:30 Potential Benefits of DPP4 Inhibitors Beyond Glycemic Control: Calcific Aortic Valve Disease Jae-kwan SONG (Department of Cardiology, University of Ulsan, Korea)
16:30-16:50 Optimal Combination Therapy for T2DM, DPP-4i + SGLT-2i Jun Sung MOON (Yeungnam University, Korea)
16:50-17:10 NASH Related Clinical Drug Development: A Succinct Review of the NAFLD & NASH Landscape Marcus HOMPESCH (ProSciento, USA)
Panel Discussion
17:10-17:40
Kwang Joon KIM (Department of Geriatrics, Yonsei University , Korea)
Hye Soon KIM (Keimyung University, Korea)
Satellite Symposium 5: Better Patient Care with Diabetes in Asian: Suggestion from Gemigliptin Day 1, October 27(Thu), 2022 / 16:10-17:40 / Room 2

Chairperson : Moon-Kyu LEE (Eulji University, Korea), Jeong-Taek WOO (Kyung Hee University, Korea)

16:10-16:30 Trends in Characteristics and Treatment of Type 2 Diabetes in Thailand Swangjit SURA-AMORNKUL (Navamindradhiraj University, Thailand)
16:30-16:50 Trends in Characteristics and Treatment of Type 2 Diabetes in Philippines Jeremy F. ROBLES (Cebu Institute of Medicine, Philippine)
16:50-17:10 Trends in Characteristics and Treatment of Type 2 Diabetes in Korea So Hun KIM (Inha University, Korea)
17:10-17:30 Clinical Benefits of Gemigliptin for the Treatment of T2DM Jeong Hyun PARK (Inje University, Korea)
Satellite Symposium 6: Strategic Approach for Individualized T2DM Patient Profile Day 1, October 27(Thu), 2022 / 16:10-17:40 / Room 3

Chairperson : Kwan Woo LEE (Ajou University, Korea), Yu-Bae AHN (The Catholic University of Korea, Korea)

16:10-16:30 DPP4i and Patient-tailored Treatment Juliana CHAN (The Chinese University of Hong Kong, Hong Kong SAR)
16:30-16:50 TZD, Benefits on T2DM Patients beyond Glycemic Control Chih-Yuan WANG (National Taiwan University, Taiwan)
16:50-17:10 What to Consider for Early Combination with DPP4-I & TZD Yongho LEE (Yonsei University, Korea)
Panel Discussion
17:10-17:40
Young Sang LYU (Chosun University, Korea)
Mihae SEO (Soonchunhyang University, Korea)
KOREAN ENDOCRINE SOCIETY
101-2503, Lotte Castle President, 109, Mapo-gu, Seoul (04146), Republic of Korea
T. +82-2-714-2428  |  E. endo@endocrinology.or.kr  |  W. www.endocrinology.or.kr
Business Registration Number: 106-82-31133  |  Name of Representative : Soon Jib Yoo
SICEM SECRETARIAT
#1101, 220, Gonghang-daero, Gangseo-gu, Seoul (07806), Republic of Korea
T. +82-2-6734-1011/1012/1013  |  E. info@sicem.kr  |   W. www.sicem.kr

Copyright ⓒ The Korean Endocrine Society. All rights Reserved